Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

381
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
381
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

17.4K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
17.4K
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

9.4K
During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...
9.4K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.6K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

YAP plays a critical role in myocardial recovery from myocarditis by suppressing IFN-γ signaling pathway.

Cardiovascular research·2026
Same author

Reduced Myocardial Serine Synthesis Impairs Functional, Metabolic, and Redox Adaptations to Cardiac Stress.

bioRxiv : the preprint server for biology·2026
Same author

A decline in skeletal muscle NOX4 abrogates exercise-induced adaptive homeostasis and exacerbates biological aging.

Science advances·2026
Same author

YAP mediates activation of the serine synthesis pathway in the heart during pressure overload.

Journal of molecular and cellular cardiology·2026
Same author

Decoding the Mitochondrial Translation-Stress Axis: Is TARS2 the Missing Link in DCM Pathogenesis?

JACC. Basic to translational science·2026
Same author

Perm1 enhances Nrf2-driven antioxidant defense through Keap1 oxidation during myocardial ischemia/reperfusion injury.

JCI insight·2026

Related Experiment Video

Updated: Feb 20, 2026

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.2K

NADPH oxidase and cardiac failure.

Junya Kuroda1, Junichi Sadoshima

  • 1Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, 185 S Orange Ave., MSB G609, Newark, NJ 07103, USA.

Journal of Cardiovascular Translational Research
|June 19, 2010
PubMed
Summary

Oxidative stress contributes to heart failure. The enzyme Nox4, a source of reactive oxygen species, plays a key role in cardiac dysfunction and may be a therapeutic target.

More Related Videos

ROS Live Cell Imaging During Neuronal Development
09:25

ROS Live Cell Imaging During Neuronal Development

Published on: February 9, 2021

4.9K
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
10:42

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models

Published on: October 22, 2012

16.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.2K
ROS Live Cell Imaging During Neuronal Development
09:25

ROS Live Cell Imaging During Neuronal Development

Published on: February 9, 2021

4.9K
Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
10:42

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models

Published on: October 22, 2012

16.8K

Area of Science:

  • Cardiovascular Biology
  • Oxidative Stress Research
  • Molecular Cardiology

Background:

  • Oxidative stress is implicated in heart failure pathogenesis, including hypertrophy, apoptosis, and fibrosis.
  • Mitochondrial electron transport chain leakage was considered the primary source of cardiac oxidative stress.
  • Emerging evidence highlights reactive oxygen species-producing enzymes as significant contributors.

Purpose of the Study:

  • To review the role of NADPH oxidases (NOX) as sources of oxidative stress in heart failure.
  • To discuss the specific contribution of Nox4 to cardiac myocyte dysfunction and heart failure.
  • To evaluate Nox4 as a potential therapeutic target for heart failure treatment.

Main Methods:

  • Literature review focusing on NADPH oxidases and their role in cardiac pathology.
  • Analysis of studies investigating Nox4 expression and function in cardiac myocytes.
  • Synthesis of evidence linking Nox4-derived reactive oxygen species to hypertrophy, apoptosis, and mitochondrial dysfunction.

Main Results:

  • NADPH oxidases, particularly Nox4, are significant sources of superoxide production in the heart.
  • Nox4 is localized to mitochondria in cardiac myocytes and its upregulation exacerbates oxidative stress.
  • Increased Nox4 activity correlates with cardiac hypertrophy, apoptosis, and mitochondrial dysfunction, contributing to heart failure.

Conclusions:

  • Nox4 is a critical mediator of oxidative stress and pathological cardiac hypertrophy.
  • Targeting Nox4 may offer a novel therapeutic strategy for managing heart failure.
  • Understanding Nox4's role is essential for developing effective heart failure treatments.